https://www.selleckchem.com/pr....oducts/BAY-73-4506.h
Our findings that betulinic acid increases apoptotic cell death and clonogenic activity under hypoxic conditions reveal new attractive strategies for treating hypoxic cancer tumors, such as NSCLC. To provide an overview of drug treatment, transplantation, and gene therapy for patients with primary immunodeficiencies. Non-systematic review of the literature in the English language carried out at PubMed. The treatment of patients with primary immunodeficiencies aims to control their disease, especially the treatment and prevention of
Like
Comment
Share
